<p>BioRestorative Therapies, Inc.（OTCMKTS:BRTXQ - 获取免费报告）的股票在周二交易中下跌了 2.7%。该公司的股价最低曾达到$1.0550，最后交易价为$1.08。在午盘交易中，共交易了 26,495 股，较平均交易量 62,169,492 股下降了 100%。该股票此前收盘价为$1.11。</p>
<h2>BioRestorative Therapies 股票下跌 2.7%</h2>
<p>该公司的五十日移动平均价为$1.40，二百日移动平均价为$1.53。该公司的市值为 17.7 亿美元，市盈率为-1.01，贝塔值为 102.36。</p>
<h2>关于 BioRestorative Therapies</h2>
<p>(获取免费报告)</p>
<p>BioRestorative Therapies, Inc.开发使用细胞和组织协议的治疗产品，主要涉及成人干细胞。该公司的两个核心项目与椎间盘/脊柱疾病和代谢紊乱的治疗相关。其椎间盘/脊柱项目包括一个主要的细胞治疗候选药物 BRTX-100，该产品由从患者骨髓中收集的自体（或个人自身）培养的间充质干细胞制成，旨在非手术治疗疼痛的腰骶椎间盘疾病。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，而不是 BioRestorative Therapies</li>
<li>3 只超市股票证明它们仍然是必需品</li>
<li>消费者得到了煤炭，但圣诞老人给这两家零售商带来了巨大的收益</li>
<li>股票评级和推荐：理解分析师评级</li>
<li>10 倍收益？这三只机器人股票可能在 2035 年前爆发</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>安海斯 - 布希收购 BeatBox 以赢得年轻饮酒者</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 BioRestorative Therapies 吗？</h2>
<p>在考虑 BioRestorative Therapies 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 BioRestorative Therapies 并不在名单上。</p>
<p>虽然 BioRestorative Therapies 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

BRTX

<p>BioRestorative Therapies (OTCMKTS:BRTXQ) 的股价下跌了 2.7%，至 1.08 美元，交易量显著低于平均水平。该股票的五十日移动平均线为 1.40 美元，二百日移动平均线为 1.53 美元。分析师目前对该股票的评级为持有，但建议其他股票可能是更好的投资选择</p>

<p>Shares of BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report) traded down 2.7% during trading on Tuesday . The company traded as low as $1.0550 and last traded at $1.08. 26,495 shares were traded during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.11.</p>
<div class="lb-trans"><p>BioRestorative Therapies, Inc.（OTCMKTS:BRTXQ - 获取免费报告）的股票在周二交易中下跌了 2.7%。该公司的股价最低曾达到$1.0550，最后交易价为$1.08。在午盘交易中，共交易了 26,495 股，较平均交易量 62,169,492 股下降了 100%。该股票此前收盘价为$1.11。</p>
</div><h2>BioRestorative Therapies Stock Down 2.7%</h2>
<div class="lb-trans"><h2>BioRestorative Therapies 股票下跌 2.7%</h2>
</div><p>The firm's fifty day moving average is $1.40 and its two-hundred day moving average is $1.53. The firm has a market cap of $1.77 billion, a P/E ratio of -1.01 and a beta of 102.36.</p>
<div class="lb-trans"><p>该公司的五十日移动平均价为$1.40，二百日移动平均价为$1.53。该公司的市值为 17.7 亿美元，市盈率为-1.01，贝塔值为 102.36。</p>
</div><h2>About BioRestorative Therapies</h2>
<div class="lb-trans"><h2>关于 BioRestorative Therapies</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.</p>
<div class="lb-trans"><p>BioRestorative Therapies, Inc.开发使用细胞和组织协议的治疗产品，主要涉及成人干细胞。该公司的两个核心项目与椎间盘/脊柱疾病和代谢紊乱的治疗相关。其椎间盘/脊柱项目包括一个主要的细胞治疗候选药物 BRTX-100，该产品由从患者骨髓中收集的自体（或个人自身）培养的间充质干细胞制成，旨在非手术治疗疼痛的腰骶椎间盘疾病。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than BioRestorative Therapies</li>
<li>3 Grocery Stocks That Are Proving They Are Still Essential</li>
<li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li>
<li>Stock Ratings and Recommendations: Understanding Analyst Ratings</li>
<li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li>
<li>What is MarketRank™? How to Use it</li>
<li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 BioRestorative Therapies</li>
<li>3 只超市股票证明它们仍然是必需品</li>
<li>消费者得到了煤炭，但圣诞老人给这两家零售商带来了巨大的收益</li>
<li>股票评级和推荐：理解分析师评级</li>
<li>10 倍收益？这三只机器人股票可能在 2035 年前爆发</li>
<li>什么是 MarketRank™？如何使用它</li>
<li>安海斯 - 布希收购 BeatBox 以赢得年轻饮酒者</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in BioRestorative Therapies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 BioRestorative Therapies 吗？</h2>
</div><p>Before you consider BioRestorative Therapies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 BioRestorative Therapies 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 BioRestorative Therapies 并不在名单上。</p>
</div><p>While BioRestorative Therapies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 BioRestorative Therapies 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

BioRestorative Therapies (OTCMKTS:BRTXQ) 的股价下跌了 2.7% - 现在是卖出的时候吗？